Javier Fernández-Ruiz
22PUBLICATIONS
26CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (22)
Sort by Publication Date:
|Oct 11, 2025
Relevance of a peripheral site of action outside the brain-blood barrier for the beneficial effects of CB2 receptor activation in experimental ALS in male mice.Marta Gómez-Almería, Claudia Gonzalo-Consuegra, Carmen Rodríguez-Cueto
|May 15, 2025
Neurodegenerative Diseases: Pathogenesis and Preclinical Models for Translational Drug Discovery.Laura Fusaro, Dinesh S Bangari, R Jeroen Pasterkamp
|Nov 02, 2024
Investigation in the cannabigerol derivative VCE-003.2 as a disease-modifying agent in a mouse model of experimental synucleinopathy.Sonia Burgaz, Elisa Navarro, Santiago Rodríguez-Carreiro
|Sep 28, 2024
Beneficial Effect of Dimethyl Fumarate Drug Repositioning in a Mouse Model of TDP-43-Dependent Frontotemporal Dementia.Ignacio Silva-Llanes, Raquel Martín-Baquero, Alicia Berrojo-Armisen
|Jan 11, 2024
From Alzheimer's disease to vascular dementia: Different roads leading to cognitive decline.Aurora Semerano, Javier Fernández-Ruiz, Marta Cortes-Canteli
|Sep 28, 2023
The Cannabigerol Derivative VCE-003.2 Exerts Therapeutic Effects in 6-Hydroxydopamine-Lesioned Mice: Comparison with The Classic Dopaminergic Replacement Therapy.Santiago Rodríguez-Carreiro, Elisa Navarro, Eduardo Muñoz
Pageof 4
Frequent Collaborators
8 joint publications
Eva de Lago
6 joint publications
Eduardo Muñoz
3 joint publications
Paula Morales
3 joint publications
Nadine Jagerovic
2 joint publications
Isabel Lastres-Becker
1 joint publications
Francisco Espejo-Porras
1 joint publications
Gemma Navarro
1 joint publications
Laura Pérez-Benito
1 joint publications
Arnau Cordomí
1 joint publications
Leonardo Pardo
